Correlation Between Vertex Pharmaceuticals and US Bancorp
Can any of the company-specific risk be diversified away by investing in both Vertex Pharmaceuticals and US Bancorp at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vertex Pharmaceuticals and US Bancorp into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Vertex Pharmaceuticals and US Bancorp, you can compare the effects of market volatilities on Vertex Pharmaceuticals and US Bancorp and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vertex Pharmaceuticals with a short position of US Bancorp. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vertex Pharmaceuticals and US Bancorp.
Diversification Opportunities for Vertex Pharmaceuticals and US Bancorp
0.62 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Vertex and USB is 0.62. Overlapping area represents the amount of risk that can be diversified away by holding Vertex Pharmaceuticals and US Bancorp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on US Bancorp and Vertex Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vertex Pharmaceuticals are associated (or correlated) with US Bancorp. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of US Bancorp has no effect on the direction of Vertex Pharmaceuticals i.e., Vertex Pharmaceuticals and US Bancorp go up and down completely randomly.
Pair Corralation between Vertex Pharmaceuticals and US Bancorp
Assuming the 90 days trading horizon Vertex Pharmaceuticals is expected to generate 1.48 times less return on investment than US Bancorp. In addition to that, Vertex Pharmaceuticals is 1.12 times more volatile than US Bancorp. It trades about 0.06 of its total potential returns per unit of risk. US Bancorp is currently generating about 0.11 per unit of volatility. If you would invest 70,997 in US Bancorp on August 29, 2024 and sell it today you would earn a total of 30,553 from holding US Bancorp or generate 43.03% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Vertex Pharmaceuticals vs. US Bancorp
Performance |
| Timeline |
| Vertex Pharmaceuticals |
| US Bancorp |
Vertex Pharmaceuticals and US Bancorp Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Vertex Pharmaceuticals and US Bancorp
The main advantage of trading using opposite Vertex Pharmaceuticals and US Bancorp positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vertex Pharmaceuticals position performs unexpectedly, US Bancorp can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in US Bancorp will offset losses from the drop in US Bancorp's long position.| Vertex Pharmaceuticals vs. Prudential Financial | Vertex Pharmaceuticals vs. Lloyds Banking Group | Vertex Pharmaceuticals vs. DXC Technology | Vertex Pharmaceuticals vs. Samsung Electronics Co |
| US Bancorp vs. McEwen Mining | US Bancorp vs. Grupo Sports World | US Bancorp vs. Prudential Financial | US Bancorp vs. Samsung Electronics Co |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data |